←Back to Expert Scholars
Translational Medicine / 转化医学Lung Oncogenic Fusions
Sai-Hong Ignatius Ou
MD, PhD
🏢UC Irvine Chao Family Comprehensive Cancer Center🌐USA
Professor of Medicine
72
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sai-Hong Ignatius Ou is a leading clinical investigator in ALK and ROS1 NSCLC treatment. His trials have advanced crizotinib, alectinib, lorlatinib and repotrectinib for fusion-positive disease. He has extensive experience in resistance profiling and novel agent development.
Share:
🧪Research Fields 研究领域
ALK fusions
ROS1 fusions
Crizotinib
Next-gen TKIs
Resistance mechanisms
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sai-Hong Ignatius Ou 的研究动态
Follow Sai-Hong Ignatius Ou's research updates
留下邮箱，当我们发布与 Sai-Hong Ignatius Ou（UC Irvine Chao Family Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment